Prolonged Clopidogrel Use is Associated with Improved Clinical Outcomes Following Drug-Eluting But Not Bare Metal Stent Implantation

Background Guidelines recommend clopidogrel use for 6–12 months following drug-eluting stent (DES) implantation and 1–12 months following bare metal stent (BMS) implantation. The role of clopidogrel beyond 12 months is unclear.